

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | humoral immune response (GO:0006959) | 9.16830435 |
| 2 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 6.21748734 |
| 3 | B cell receptor signaling pathway (GO:0050853) | 6.21696856 |
| 4 | negative regulation of glucose import (GO:0046325) | 5.92358835 |
| 5 | signal peptide processing (GO:0006465) | 5.71665731 |
| 6 | cytidine deamination (GO:0009972) | 5.16220536 |
| 7 | cytidine metabolic process (GO:0046087) | 5.16220536 |
| 8 | cytidine catabolic process (GO:0006216) | 5.16220536 |
| 9 | negative regulation of B cell proliferation (GO:0030889) | 5.14206757 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07843724 |
| 11 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.02885063 |
| 12 | negative regulation of glucose transport (GO:0010829) | 4.84526484 |
| 13 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.81306540 |
| 14 | Fc receptor signaling pathway (GO:0038093) | 4.74728336 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 4.69611478 |
| 16 | cellular response to zinc ion (GO:0071294) | 4.57172325 |
| 17 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.47481927 |
| 18 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.33115767 |
| 19 | phenylpropanoid metabolic process (GO:0009698) | 4.32133275 |
| 20 | regulation of B cell proliferation (GO:0030888) | 4.23359977 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22060421 |
| 22 | regulation of B cell differentiation (GO:0045577) | 4.17898125 |
| 23 | immune response-activating signal transduction (GO:0002757) | 3.89992659 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.76585867 |
| 25 | B cell proliferation (GO:0042100) | 3.65646784 |
| 26 | positive regulation of macrophage cytokine production (GO:0060907) | 3.62062625 |
| 27 | activation of immune response (GO:0002253) | 3.52808208 |
| 28 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.46254778 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.41107809 |
| 30 | proline biosynthetic process (GO:0006561) | 3.36266279 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.35632758 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.35632758 |
| 33 | positive regulation of immunoglobulin production (GO:0002639) | 3.30533520 |
| 34 | fucose catabolic process (GO:0019317) | 3.20460327 |
| 35 | L-fucose metabolic process (GO:0042354) | 3.20460327 |
| 36 | L-fucose catabolic process (GO:0042355) | 3.20460327 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.17924683 |
| 38 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.06278438 |
| 39 | complement activation, classical pathway (GO:0006958) | 26.2242529 |
| 40 | complement activation (GO:0006956) | 20.1019046 |
| 41 | regulation of B cell apoptotic process (GO:0002902) | 2.97812342 |
| 42 | regulation of B cell activation (GO:0050864) | 2.95178255 |
| 43 | respiratory burst (GO:0045730) | 2.90971675 |
| 44 | positive regulation of protein homooligomerization (GO:0032464) | 2.88454354 |
| 45 | negative T cell selection (GO:0043383) | 2.87023310 |
| 46 | negative regulation of B cell activation (GO:0050869) | 2.86209874 |
| 47 | mast cell activation (GO:0045576) | 2.82355516 |
| 48 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.72682117 |
| 49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.70817405 |
| 50 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.68673065 |
| 51 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.63994634 |
| 52 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.63453483 |
| 53 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.59023905 |
| 54 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.56062761 |
| 55 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.56062761 |
| 56 | antibacterial humoral response (GO:0019731) | 2.53642065 |
| 57 | tissue homeostasis (GO:0001894) | 2.52956769 |
| 58 | polyketide metabolic process (GO:0030638) | 2.51282211 |
| 59 | doxorubicin metabolic process (GO:0044598) | 2.51282211 |
| 60 | daunorubicin metabolic process (GO:0044597) | 2.51282211 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 2.49473779 |
| 62 | regulation of macrophage cytokine production (GO:0010935) | 2.48673533 |
| 63 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.48055446 |
| 64 | regulation of superoxide anion generation (GO:0032928) | 2.47025872 |
| 65 | thymic T cell selection (GO:0045061) | 2.42734724 |
| 66 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.41865767 |
| 67 | regulation of immunoglobulin production (GO:0002637) | 2.40441850 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39222206 |
| 69 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.39186177 |
| 70 | antimicrobial humoral response (GO:0019730) | 2.39066200 |
| 71 | T cell selection (GO:0045058) | 2.36732043 |
| 72 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.35670723 |
| 73 | B cell homeostasis (GO:0001782) | 2.34575065 |
| 74 | xenobiotic catabolic process (GO:0042178) | 2.34123724 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.33736008 |
| 76 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.33178801 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.28794529 |
| 78 | positive thymic T cell selection (GO:0045059) | 2.28355915 |
| 79 | B cell activation (GO:0042113) | 2.26836307 |
| 80 | positive regulation of B cell proliferation (GO:0030890) | 2.25158657 |
| 81 | regulation of gamma-delta T cell activation (GO:0046643) | 2.24950041 |
| 82 | positive regulation of B cell activation (GO:0050871) | 2.23517622 |
| 83 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.22714012 |
| 84 | Golgi transport vesicle coating (GO:0048200) | 2.22343108 |
| 85 | COPI coating of Golgi vesicle (GO:0048205) | 2.22343108 |
| 86 | proline metabolic process (GO:0006560) | 2.20534705 |
| 87 | negative regulation of B cell apoptotic process (GO:0002903) | 2.18388130 |
| 88 | V(D)J recombination (GO:0033151) | 2.18027663 |
| 89 | peptidyl-asparagine modification (GO:0018196) | 2.17990638 |
| 90 | I-kappaB phosphorylation (GO:0007252) | 2.17332613 |
| 91 | positive regulation of Rap GTPase activity (GO:0032854) | 2.13471880 |
| 92 | mast cell activation involved in immune response (GO:0002279) | 2.12071147 |
| 93 | mast cell degranulation (GO:0043303) | 2.12071147 |
| 94 | mature B cell differentiation (GO:0002335) | 2.11614341 |
| 95 | protein activation cascade (GO:0072376) | 13.0710052 |
| 96 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 11.2893240 |
| 97 | Fc-gamma receptor signaling pathway (GO:0038094) | 11.2893240 |
| 98 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 11.2893240 |
| 99 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 11.1531421 |
| 100 | retina homeostasis (GO:0001895) | 10.0788884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.60512349 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.22620645 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.01355378 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.95510482 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.46327650 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.11721887 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 4.06187817 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.87940708 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.57182426 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00939640 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.98905330 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90529119 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.84782642 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.73347423 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.64692522 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.47226273 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39479407 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.34096063 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33540884 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.32778451 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.22307128 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10184550 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.08803579 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.98065078 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 1.93905690 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91554799 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87227478 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85228188 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80411924 |
| 30 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.79649362 |
| 31 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.76212742 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73103574 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72237652 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71817744 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71377694 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69884626 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.68508275 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67942742 |
| 39 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.65069801 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57767215 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.56893523 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54287461 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52748666 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48847517 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47998025 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46299766 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43077964 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41303570 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40300040 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37072730 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34428950 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32046829 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31925325 |
| 54 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.29416404 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23192488 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21584657 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20862744 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20457048 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17651429 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17183992 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16682462 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16636944 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.14256396 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14069237 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12454888 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08898918 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08501176 |
| 68 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.08402555 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08141994 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07778775 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07210680 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07204955 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06590392 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04604436 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04479076 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04029346 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03993220 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03615054 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00156179 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00077911 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98299144 |
| 82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94060104 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92282547 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90466879 |
| 85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88354420 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87389875 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84347909 |
| 88 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83987616 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83389871 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82525578 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82332482 |
| 92 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.81413403 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81361168 |
| 94 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.78611412 |
| 95 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.78484278 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77541928 |
| 97 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76807752 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76736538 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76523586 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76328460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.59927309 |
| 2 | MP0001800_abnormal_humoral_immune | 4.87171589 |
| 3 | MP0003303_peritoneal_inflammation | 4.13633415 |
| 4 | MP0005671_abnormal_response_to | 3.74306324 |
| 5 | MP0005387_immune_system_phenotype | 3.68862068 |
| 6 | MP0001790_abnormal_immune_system | 3.68862068 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.46562749 |
| 8 | MP0006054_spinal_hemorrhage | 3.07828770 |
| 9 | MP0002723_abnormal_immune_serum | 2.97719352 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.78985669 |
| 11 | MP0001819_abnormal_immune_cell | 2.72569492 |
| 12 | MP0000685_abnormal_immune_system | 2.67876882 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.67641429 |
| 14 | MP0002398_abnormal_bone_marrow | 2.63536770 |
| 15 | MP0000716_abnormal_immune_system | 2.55723982 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.53935725 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.43795450 |
| 18 | MP0000689_abnormal_spleen_morphology | 2.28847028 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.14983193 |
| 20 | MP0002429_abnormal_blood_cell | 2.06795868 |
| 21 | MP0005025_abnormal_response_to | 2.06622760 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 1.96142501 |
| 23 | MP0002006_tumorigenesis | 1.93388034 |
| 24 | MP0002722_abnormal_immune_system | 1.84404457 |
| 25 | MP0002419_abnormal_innate_immunity | 1.82628401 |
| 26 | MP0001879_abnormal_lymphatic_vessel | 1.78791875 |
| 27 | MP0004947_skin_inflammation | 1.73437981 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.70269114 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.65559599 |
| 30 | MP0003436_decreased_susceptibility_to | 1.65542594 |
| 31 | MP0005360_urolithiasis | 1.65185220 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.49434040 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.49407483 |
| 34 | MP0002405_respiratory_system_inflammati | 1.43856518 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.43076905 |
| 36 | MP0009785_altered_susceptibility_to | 1.42691140 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.40856258 |
| 38 | MP0000920_abnormal_myelination | 1.39890021 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.27010388 |
| 40 | MP0005310_abnormal_salivary_gland | 1.24480907 |
| 41 | MP0008057_abnormal_DNA_replication | 1.23951600 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.22489551 |
| 43 | MP0002933_joint_inflammation | 1.22325954 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.18894503 |
| 45 | MP0004859_abnormal_synaptic_plasticity | 1.18577341 |
| 46 | MP0001853_heart_inflammation | 1.15464259 |
| 47 | MP0006082_CNS_inflammation | 1.11104891 |
| 48 | MP0002019_abnormal_tumor_incidence | 1.09679662 |
| 49 | MP0003866_abnormal_defecation | 1.08258956 |
| 50 | MP0008569_lethality_at_weaning | 1.07157707 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.04541261 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03830865 |
| 53 | MP0009046_muscle_twitch | 1.01878603 |
| 54 | MP0004510_myositis | 1.01395680 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.00144889 |
| 56 | MP0000703_abnormal_thymus_morphology | 0.99064427 |
| 57 | MP0003045_fibrosis | 0.98831452 |
| 58 | MP0003075_altered_response_to | 0.98429592 |
| 59 | MP0002136_abnormal_kidney_physiology | 0.98390013 |
| 60 | MP0005464_abnormal_platelet_physiology | 0.92835574 |
| 61 | MP0005623_abnormal_meninges_morphology | 0.91970024 |
| 62 | MP0005332_abnormal_amino_acid | 0.88861113 |
| 63 | MP0001919_abnormal_reproductive_system | 0.86472719 |
| 64 | MP0008469_abnormal_protein_level | 0.84265251 |
| 65 | MP0003879_abnormal_hair_cell | 0.81900468 |
| 66 | MP0003880_abnormal_central_pattern | 0.81495415 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 0.81167040 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.80123698 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.80123698 |
| 70 | MP0003690_abnormal_glial_cell | 0.79556735 |
| 71 | MP0008872_abnormal_physiological_respon | 0.75047033 |
| 72 | MP0000609_abnormal_liver_physiology | 0.74864689 |
| 73 | MP0001348_abnormal_lacrimal_gland | 0.74678512 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73648344 |
| 75 | MP0005388_respiratory_system_phenotype | 0.73238801 |
| 76 | MP0002133_abnormal_respiratory_system | 0.73238801 |
| 77 | MP0009278_abnormal_bone_marrow | 0.70990862 |
| 78 | MP0000490_abnormal_crypts_of | 0.70664713 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.70390431 |
| 80 | MP0003186_abnormal_redox_activity | 0.68639561 |
| 81 | MP0002873_normal_phenotype | 0.67847875 |
| 82 | MP0002169_no_abnormal_phenotype | 0.67752774 |
| 83 | MP0005083_abnormal_biliary_tract | 0.67377256 |
| 84 | MP0002083_premature_death | 0.67177701 |
| 85 | MP0001666_abnormal_nutrient_absorption | 0.65939472 |
| 86 | MP0000604_amyloidosis | 0.62546332 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.62167833 |
| 88 | MP0001663_abnormal_digestive_system | 0.62086091 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 0.62076244 |
| 90 | MP0001958_emphysema | 0.62042888 |
| 91 | MP0004885_abnormal_endolymph | 0.61073778 |
| 92 | MP0003252_abnormal_bile_duct | 0.60152839 |
| 93 | MP0001191_abnormal_skin_condition | 0.60061589 |
| 94 | MP0009763_increased_sensitivity_to | 0.59380842 |
| 95 | MP0004142_abnormal_muscle_tone | 0.59162861 |
| 96 | MP0010329_abnormal_lipoprotein_level | 0.56219323 |
| 97 | MP0003633_abnormal_nervous_system | 0.54719325 |
| 98 | MP0008874_decreased_physiological_sensi | 0.53061963 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.51625578 |
| 100 | MP0005023_abnormal_wound_healing | 0.51363013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.28949875 |
| 2 | Abnormality of B cell number (HP:0010975) | 8.02740428 |
| 3 | B lymphocytopenia (HP:0010976) | 8.02740428 |
| 4 | Recurrent bronchitis (HP:0002837) | 6.79083582 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.64165177 |
| 6 | Cellulitis (HP:0100658) | 6.30022739 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 6.02528299 |
| 8 | Verrucae (HP:0200043) | 5.91871630 |
| 9 | Papilloma (HP:0012740) | 5.91871630 |
| 10 | Colitis (HP:0002583) | 5.02590626 |
| 11 | IgM deficiency (HP:0002850) | 4.89876484 |
| 12 | Recurrent pneumonia (HP:0006532) | 4.85381501 |
| 13 | Meningitis (HP:0001287) | 4.77290403 |
| 14 | Recurrent viral infections (HP:0004429) | 4.68305698 |
| 15 | Chronic sinusitis (HP:0011109) | 4.60218704 |
| 16 | Thyroiditis (HP:0100646) | 4.46802278 |
| 17 | Recurrent lower respiratory tract infections (HP:0002783) | 4.13295797 |
| 18 | IgG deficiency (HP:0004315) | 4.00962246 |
| 19 | Osteomyelitis (HP:0002754) | 3.84413342 |
| 20 | Bronchitis (HP:0012387) | 3.83297002 |
| 21 | Recurrent otitis media (HP:0000403) | 3.83027741 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.70272685 |
| 23 | Chronic otitis media (HP:0000389) | 3.66881887 |
| 24 | Sepsis (HP:0100806) | 3.60355990 |
| 25 | Inflammation of the large intestine (HP:0002037) | 3.60054213 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 3.45726326 |
| 27 | Emphysema (HP:0002097) | 3.33240299 |
| 28 | IgA deficiency (HP:0002720) | 3.32174351 |
| 29 | Abnormality of T cell number (HP:0011839) | 3.11773251 |
| 30 | Skin rash (HP:0000988) | 3.10205805 |
| 31 | Hypoplasia of the thymus (HP:0000778) | 3.07324984 |
| 32 | Vasculitis (HP:0002633) | 3.06958933 |
| 33 | Mitral stenosis (HP:0001718) | 3.04401971 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 2.99458692 |
| 35 | Lymphopenia (HP:0001888) | 2.91655041 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.90362468 |
| 37 | T lymphocytopenia (HP:0005403) | 2.82210374 |
| 38 | Restrictive lung disease (HP:0002091) | 2.81559425 |
| 39 | Abnormality of T cells (HP:0002843) | 2.81533560 |
| 40 | Combined immunodeficiency (HP:0005387) | 2.77147507 |
| 41 | Severe combined immunodeficiency (HP:0004430) | 2.76935837 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62333609 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.57920919 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.56218233 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.47938207 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.45344064 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39719191 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.36881820 |
| 49 | Mucosal telangiectasiae (HP:0100579) | 2.29815653 |
| 50 | Xerostomia (HP:0000217) | 2.28978816 |
| 51 | Eosinophilia (HP:0001880) | 2.16790887 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.15825255 |
| 53 | Small epiphyses (HP:0010585) | 2.13767861 |
| 54 | Skin ulcer (HP:0200042) | 2.13373085 |
| 55 | Acrocyanosis (HP:0001063) | 2.11043830 |
| 56 | Hypoproteinemia (HP:0003075) | 2.07102796 |
| 57 | Neutropenia (HP:0001875) | 2.06407067 |
| 58 | Hypertensive crisis (HP:0100735) | 2.05452936 |
| 59 | Pulmonary infiltrates (HP:0002113) | 1.98347358 |
| 60 | Lymphoma (HP:0002665) | 1.97198390 |
| 61 | Recurrent skin infections (HP:0001581) | 1.93898153 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93159173 |
| 63 | Leukopenia (HP:0001882) | 1.89987990 |
| 64 | Arthralgia (HP:0002829) | 1.89683498 |
| 65 | Myositis (HP:0100614) | 1.89635954 |
| 66 | Deep venous thrombosis (HP:0002625) | 1.89228170 |
| 67 | Colon cancer (HP:0003003) | 1.87084037 |
| 68 | Limb hypertonia (HP:0002509) | 1.83382064 |
| 69 | Nonimmune hydrops fetalis (HP:0001790) | 1.79404337 |
| 70 | Progressive macrocephaly (HP:0004481) | 1.78542040 |
| 71 | Conjunctival hamartoma (HP:0100780) | 1.77273258 |
| 72 | Papilledema (HP:0001085) | 1.75327140 |
| 73 | Acute encephalopathy (HP:0006846) | 1.72185955 |
| 74 | Abnormality of eosinophils (HP:0001879) | 1.71418628 |
| 75 | Thrombocytosis (HP:0001894) | 1.68982745 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 1.66739780 |
| 77 | Dehydration (HP:0001944) | 1.62844087 |
| 78 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.62266822 |
| 79 | Eczematoid dermatitis (HP:0000976) | 1.61635340 |
| 80 | Teleangiectasia of the skin (HP:0100585) | 1.61500151 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 1.60492460 |
| 82 | Macroorchidism (HP:0000053) | 1.60220770 |
| 83 | Abnormality of the intrinsic pathway (HP:0010989) | 1.58260482 |
| 84 | Bronchiectasis (HP:0002110) | 1.55861408 |
| 85 | Mediastinal lymphadenopathy (HP:0100721) | 1.55567024 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 1.52979903 |
| 87 | Leukocytosis (HP:0001974) | 1.51068394 |
| 88 | Ulnar bowing (HP:0003031) | 1.50744812 |
| 89 | Nasal polyposis (HP:0100582) | 1.50561352 |
| 90 | Granulocytopenia (HP:0001913) | 1.48147786 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 1.47589156 |
| 92 | Camptodactyly of toe (HP:0001836) | 1.47435606 |
| 93 | Keratoconjunctivitis (HP:0001096) | 1.44781325 |
| 94 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.44090178 |
| 95 | Cholelithiasis (HP:0001081) | 1.43826467 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.41511263 |
| 97 | Obstructive lung disease (HP:0006536) | 1.41511263 |
| 98 | Leukodystrophy (HP:0002415) | 1.41303850 |
| 99 | Stomatitis (HP:0010280) | 1.41238150 |
| 100 | Hyperventilation (HP:0002883) | 1.40754744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.96787559 |
| 2 | ERN1 | 4.77499873 |
| 3 | RIPK4 | 3.21022735 |
| 4 | GRK6 | 3.07039638 |
| 5 | MAP3K10 | 3.02235315 |
| 6 | SYK | 2.99461370 |
| 7 | CSF1R | 2.44718877 |
| 8 | BUB1 | 2.29694030 |
| 9 | LYN | 2.20054342 |
| 10 | BLK | 2.16627373 |
| 11 | SIK2 | 2.08185216 |
| 12 | PRKCH | 2.05571135 |
| 13 | BTK | 2.04210287 |
| 14 | KIT | 2.02779147 |
| 15 | MAP3K14 | 1.85555295 |
| 16 | EIF2AK3 | 1.85521097 |
| 17 | FES | 1.75853712 |
| 18 | TYK2 | 1.75088263 |
| 19 | MAP3K13 | 1.72198104 |
| 20 | FRK | 1.68672314 |
| 21 | BCKDK | 1.66300582 |
| 22 | CLK1 | 1.62626883 |
| 23 | IRAK4 | 1.60008898 |
| 24 | MST4 | 1.59730471 |
| 25 | TBK1 | 1.56506823 |
| 26 | FGFR2 | 1.47000145 |
| 27 | NEK2 | 1.43459796 |
| 28 | ITK | 1.37809755 |
| 29 | PRKCQ | 1.35411515 |
| 30 | MAP3K4 | 1.31636240 |
| 31 | HCK | 1.23428829 |
| 32 | STK10 | 1.23368453 |
| 33 | PIK3CG | 1.22726343 |
| 34 | SIK1 | 1.13094240 |
| 35 | FGFR3 | 1.09514789 |
| 36 | JAK1 | 1.05185964 |
| 37 | IRAK3 | 1.04139106 |
| 38 | LCK | 1.01369039 |
| 39 | MATK | 0.97160324 |
| 40 | BMX | 0.96803398 |
| 41 | PIM1 | 0.95040103 |
| 42 | LRRK2 | 0.93444714 |
| 43 | NME2 | 0.91972379 |
| 44 | HIPK2 | 0.91388896 |
| 45 | UHMK1 | 0.87424552 |
| 46 | CSK | 0.86854363 |
| 47 | FYN | 0.84641406 |
| 48 | TTN | 0.83291624 |
| 49 | PRKCI | 0.82267219 |
| 50 | PRKD1 | 0.82261229 |
| 51 | IKBKB | 0.79790262 |
| 52 | NEK1 | 0.79765592 |
| 53 | CSNK1G3 | 0.79189524 |
| 54 | PKN1 | 0.77157802 |
| 55 | BRSK1 | 0.76729538 |
| 56 | PRKCD | 0.72783365 |
| 57 | CSNK1A1L | 0.71755279 |
| 58 | TAOK3 | 0.69199018 |
| 59 | TGFBR2 | 0.65724335 |
| 60 | MAPK12 | 0.63341796 |
| 61 | CSNK1G2 | 0.62818401 |
| 62 | MAPK4 | 0.60899487 |
| 63 | KSR2 | 0.60800350 |
| 64 | TEC | 0.59846760 |
| 65 | FGFR4 | 0.59706501 |
| 66 | MAP3K9 | 0.59584783 |
| 67 | MARK3 | 0.52606260 |
| 68 | MAPK7 | 0.51278298 |
| 69 | ALK | 0.51057406 |
| 70 | IKBKE | 0.50205873 |
| 71 | CSNK1G1 | 0.47412539 |
| 72 | BMPR2 | 0.46438734 |
| 73 | CDC42BPA | 0.46384029 |
| 74 | BCR | 0.45847830 |
| 75 | EEF2K | 0.45755726 |
| 76 | INSR | 0.45725646 |
| 77 | NME1 | 0.43942732 |
| 78 | RPS6KA6 | 0.40679832 |
| 79 | NTRK3 | 0.38944142 |
| 80 | ABL1 | 0.38316104 |
| 81 | RPS6KC1 | 0.36129992 |
| 82 | RPS6KL1 | 0.36129992 |
| 83 | MAP2K1 | 0.35254278 |
| 84 | RPS6KB2 | 0.34671949 |
| 85 | JAK3 | 0.33423715 |
| 86 | MAPKAPK2 | 0.33255376 |
| 87 | PRKCZ | 0.33189860 |
| 88 | CDK15 | 0.32626892 |
| 89 | MAP3K8 | 0.32304725 |
| 90 | EIF2AK2 | 0.30999020 |
| 91 | CSNK1D | 0.29792435 |
| 92 | JAK2 | 0.27166494 |
| 93 | CDK18 | 0.26837200 |
| 94 | NEK9 | 0.26207322 |
| 95 | EPHA4 | 0.25945006 |
| 96 | CAMKK1 | 0.23428859 |
| 97 | PDK1 | 0.23090934 |
| 98 | DYRK1B | 0.22965090 |
| 99 | MAPK11 | 0.22902350 |
| 100 | SRC | 0.22468413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 8.78708009 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.14317645 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.25358090 |
| 4 | Protein export_Homo sapiens_hsa03060 | 4.05031077 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48517194 |
| 6 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.86845922 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 1.70354149 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.63038166 |
| 9 | Asthma_Homo sapiens_hsa05310 | 1.57672422 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48766500 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 1.47231034 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46617095 |
| 13 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42508523 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.31422215 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31268642 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21821718 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.19420548 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15144550 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.13597779 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08433713 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99810535 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99109785 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 0.99071430 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98946435 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97268821 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93210366 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92121291 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91990551 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 0.90669277 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87815406 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87754536 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87476098 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87320199 |
| 34 | Malaria_Homo sapiens_hsa05144 | 0.83836139 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83722164 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83540818 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83065301 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82385311 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 0.79617787 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73647322 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72293263 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70563890 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68384172 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65601053 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65175750 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64841020 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62784458 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61772639 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61183163 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57826924 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56061717 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52903896 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52857977 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52117997 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49837970 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49543920 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48489510 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47959879 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47931488 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46894192 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45729659 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44010213 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43679459 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42435724 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41786497 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41763526 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39655147 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38031872 |
| 69 | Ribosome_Homo sapiens_hsa03010 | 0.36508078 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33784564 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32932369 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32193715 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31888220 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.31356622 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30405293 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29790190 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29572086 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29274398 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.28906471 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28901256 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.28742099 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28017666 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27365535 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26997925 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26376631 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26069533 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26047895 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.25694184 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25364796 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.25004038 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23249719 |
| 92 | Measles_Homo sapiens_hsa05162 | 0.22488592 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.21626935 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.20712997 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20518201 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19012624 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.17669498 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.17593201 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.16286015 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.15606984 |

